Janne Verho
Papers
1
Total Citations
6
H-Index
1
About
Janne Verho is a leading researcher in oncologic imaging, with a primary focus on improving the detection and staging of prostate cancer. Her most cited work, a prospective 2025 study, rigorously compared 18F-PSMA-1007 PET/CT and whole-body MRI with histopathology as the gold standard for intraprostatic tumour detection and T-staging in high-risk prostate cancer. This landmark study, garnering 6 citations, is pivotal for its direct, head-to-head evaluation of two advanced imaging modalities. Beyond diagnostic accuracy, Verho’s research uniquely correlates PSMA uptake on PET/CT with immunohistochemical expression of PSMA, bridging non-invasive imaging with molecular pathology. Her contributions are critical for refining clinical workflows, potentially reducing the need for invasive biopsies and improving surgical planning. By providing high-level evidence for the comparative performance of PSMA-PET and multiparametric MRI, Verho’s work directly impacts treatment decisions for high-risk patients. Her research stands as a cornerstone for future guidelines on prostate cancer imaging, demonstrating a clear commitment to translating advanced imaging biomarkers into tangible clinical benefit.
Research Focus
Key Achievements
Top Papers
- 1